Cargando…
Communication Challenges During the Development and Introduction of a New Meningococcal Vaccine in Africa
Background. A new group A meningococcal conjugate vaccine was developed to eliminate deadly meningitis epidemics in sub-Saharan Africa. Methods. From the outset of the project, advocacy and communication strategies were developed and adjusted as the project evolved in Europe, Africa, India, and the...
Autores principales: | Berlier, Monique, Barry, Rodrigue, Shadid, John, Sirica, Coimbra, Brunier, Alison, Hasan, Hayatee, Bouma, Enricke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639482/ https://www.ncbi.nlm.nih.gov/pubmed/26553674 http://dx.doi.org/10.1093/cid/civ493 |
Ejemplares similares
-
Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials
por: Idoko, Olubukola T., et al.
Publicado: (2015) -
Technical Development of a New Meningococcal Conjugate Vaccine
por: Frasch, Carl E., et al.
Publicado: (2015) -
Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010–2014
por: Djingarey, Mamoudou H., et al.
Publicado: (2015) -
Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004–2013
por: Lingani, Clément, et al.
Publicado: (2015) -
Documenting the Results of a Successful Partnership: A New Meningococcal Vaccine for Africa
por: Okwo-Bele, Jean-Marie, et al.
Publicado: (2015)